Coherus BioSciences Cash from Financing (TTM) Analysis

Coherus BioSciences Inc (CHRS)

2.055 +0.06 (+2.75%) USD | NASDAQ | Apr 19, 16:00

2.055 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	69.60M
September 30, 2023	75.83M
June 30, 2023	113.59M
March 31, 2023	59.98M
December 31, 2022	54.33M
September 30, 2022	49.22M
June 30, 2022	1.454M
March 31, 2022	47.58M
December 31, 2021	51.88M
September 30, 2021	55.90M
June 30, 2021	58.89M
March 31, 2021	222.46M
December 31, 2020	223.95M
September 30, 2020	219.63M
June 30, 2020	219.23M
March 31, 2020	11.82M
December 31, 2019	89.37M
September 30, 2019	90.76M
June 30, 2019	88.14M

Date	Value
March 31, 2019	185.02M
December 31, 2018	105.42M
September 30, 2018	109.72M
June 30, 2018	183.74M
March 31, 2018	83.67M
December 31, 2017	206.79M
September 30, 2017	255.89M
June 30, 2017	182.07M
March 31, 2017	251.33M
December 31, 2016	226.18M
September 30, 2016	170.51M
June 30, 2016	179.72M
March 31, 2016	223.26M
December 31, 2015	122.69M
September 30, 2015	206.12M
June 30, 2015	193.88M
March 31, 2015	135.22M
December 31, 2014	135.96M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

1.454M

Minimum

Jun 2022

223.95M

Maximum

Dec 2020

94.93M

Average

69.60M

Median

Dec 2023

Cash from Financing (TTM) Benchmarks